Alexios Matikas

18PUBLICATIONS
100CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyCancer geneticsSocial determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 17, 2026
Development and validation of a machine learning clinicogenomic model to improve prognostic stratification in ER-positive/HER2-negative early breast cancer.

|Jun 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

|Apr 08, 2026
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial.

Alexios Matikas, Evangelos Tzoras, Michail Sarafidis

|Aug 27, 2025
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.

Alexios Matikas, Bjørn Naume, Hans Wildiers

|Mar 07, 2025
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.

Ioannis Zerdes, Alexios Matikas, Artur Mezheyeuski

|Feb 24, 2025
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status.

Matteo Lambertini, Eva Blondeaux, Loredana M Tomasello

Pageof 3

Frequent Collaborators

9 joint publications

Theodoros Foukakis

8 joint publications

Jonas Bergh

6 joint publications

Ioannis Zerdes

4 joint publications

Balazs Acs